Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,610.74
(
0.14%
)
US TECH 100
29,811.60
(
0.34%
)
Dow Jones
51,337.25
(
0.51%
)
Brent Oil
95.40
(
-0.59%
)
Bitcoin
67,001.98
(
-6.12%
)
News Focus
News Focus
Post# of 257689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123054
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: pollyvonwog post# 151379

Sunday, 10/28/2012 2:38:41 PM

Sunday, October 28, 2012 2:38:41 PM

Post# of 257689
Note that MNTA has not applied for patents on Humira, Erbitux, or other FoB’s they might be thinking of working on, as far as I know. (MNTA has received a patent relating to Orencia, but it is not a process-oriented patent that would present a blueprint for a competing FoB company.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today